Liver transplantation for fulminant Wilson's disease in children

Małgorzata Markiewicz-Kijewska1, Marek Szymczak, Hor Ismail

  • 1Department of Pediatric Surgery and Organ Transplantation, Childrens Memorial Health Institute, Warsaw, Poland. gonia.mark@wp.pl

Insights

Fulminant Wilson's disease (FWD) in children is often fatal without liver transplantation. However, new therapies like albumin dialysis and chelating treatment show promise for survival and can extend transplant waiting times.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Transplant Surgery

Background:

  • Fulminant Wilson's disease (FWD) presents a rare but fatal condition in children, with liver transplantation being the primary life-saving intervention.
  • Advancements in medical technologies offer potential to improve the prognosis for pediatric patients diagnosed with FWD.

Purpose of the Study:

  • To conduct a retrospective analysis of the clinical course, treatment strategies, and outcomes of pediatric patients with FWD treated at the institution.
  • To reevaluate the eligibility for liver transplantation based on pathological findings of explanted livers.

Main Methods:

  • Retrospective analysis of 13 pediatric patients (mean age 15.5 years) with FWD treated between 1999-2007.
  • Evaluation of clinical data, biochemical parameters, MELD/PELD scores, Wilson score, and King's College criteria for liver transplantation.
  • Assessment of treatment types, outcomes, and transplant qualification in relation to explanted liver pathology.

Main Results:

  • Initial FWD symptoms included weakness, abdominal pain, and jaundice developing within 5-60 days (mean 20 days).
  • Eleven patients experienced neurological symptoms and coma preceding transplantation or death; maximal serum bilirubin ranged from 4.5-71.6 mg% (mean 42.24 mg%), INR 2.9-10.0 (mean 5.4).
  • MELD/PELD scores ranged from 21-58 (mean 38), with 10 patients meeting King's College criteria; Wilson's index averaged 13 points. Urgent liver transplantation (LTx) was performed in 11 children, one recovered with albumin dialysis and chelating treatment, and one died due to late referral. Survivors (n=12) show good liver function with a mean follow-up of 2.57 years.

Conclusions:

  • FWD is nearly universally fatal in pediatric patients without timely liver transplantation.
  • Early implementation of albumin dialysis (MARS) and chelating therapy facilitated survival in one patient and may prolong waiting times for LTx.
  • The Wilson's index demonstrated a slightly superior predictive value for LTx necessity compared to the King's College criteria in this cohort.
Abstract